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Abstract: The American Heart Association (AHA) and World Health Organization (WHO)
have recommended restricting calories from added sugars at lower levels than the Institute of
Medicine (IOM) recommendations, which are incorporated in the Dietary Guidelines for
Americans 2010 (DGAs 2010). Sucrose (SUC) and high fructose corn syrup (HFCS) have
been singled out for particular concern, because of their fructose content, which has been
specifically implicated for its atherogenic potential and possible role in elevating blood
pressure through uric acid-mediated endothelial dysfunction. This study explored the effects
when these sugars are consumed at typical population levels up to the 90th percentile
population consumption level for fructose. Three hundred fifty five overweight or obese
individuals aged 20–60 years old were placed on a eucaloric diet for 10 weeks, which
incorporated SUC- or HFCS-sweetened, low-fat milk at 8%, 18% or 30% of calories. There
was a slight change in body weight in the entire cohort (169.1 ± 30.6 vs. 171.6 ± 31.8 lbs,
p < 0.01), a decrease in HDL (52.9 ± 12.2 vs. 52.0 ± 13.9 mg/dL, p < 0.05) and an increase in
triglycerides (104.1 ± 51.8 vs. 114.1 ± 64.7 mg/dL, p < 0.001). However, total cholesterol
(183.5 ± 42.8 vs. 184.4 mg/dL, p > 0.05), LDL (110.3 ± 32.0 vs. 110.5 ± 38.9 mg/dL,
p > 0.05), SBP (109.4 ± 10.9 vs. 108.3 ± 10.9 mmHg, p > 0.05) and DBP
(72.1 ± 8.0 vs. 71.3 ± 8.0 mmHg, p > 0.05) were all unchanged. In no instance did the amount
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or type of sugar consumed affect the response to the intervention (interaction p > 0.05).
These data suggest that: (1) when consumed as part of a normal diet, common
fructose-containing sugars do not raise blood pressure, even when consumed at the 90th
percentile population consumption level for fructose (five times the upper level
recommended by the AHA and three times the upper level recommended by WHO);
(2) changes in the lipid profile are mixed, but modest.
Keywords: sugars; sucrose; HFCS; cardiac risk factors

1. Introduction
The intake of added sugars has increased in the United States between 1970 and 2005 by 19% from
400 calories to 476 calories for Americans’ average daily energy intake [1]. Increased intakes of dietary
sugar in the setting of the worldwide pandemic of cardiovascular disease (CVD) and obesity have caused
concern that added sugars may be a potential causative factor in a number of serious medical conditions
and diseases, such as coronary heart disease (CHD) [2], obesity [3–7], diabetes [8], metabolic
syndrome [9] and non-alcoholic fatty liver disease (NAFLD) [10]. It has been argued that the fructose
moiety in both sucrose (SUC) and high fructose corn syrup (HFCS) could be an underlying cause of
these adverse consequences [11–13].
With these factors as the background, a number of individuals and organizations have recommended
substantial reductions in the amount of added sugars in the American diet. For example, the American
Heart Association (AHA) has published guidelines recommending that the average American woman
should consume no more than 100 kcal per day from added sugars and the average American male no
more than 150 kcal per day from added sugars [2]. These recommendations are exceeded by over 90% of
individuals in the United States. The AHA recognized that these recommendations were not based on
randomized clinical trials. The WHO has recommended an upper limit of 10% of calories from added
sugars with an ultimate goal of a reduction to 5% of added calories [14]. Both the AHA and WHO
recommendations for upper limits of added sugars are substantially lower than the 25% upper limit
recommended by the Institute of Medicine (IOM) [15], which was also incorporated into the Dietary
Guidelines for Americans 2010 [16].
The current, randomized controlled trial (RCT) was undertaken to explore the metabolism and impact
on CHD risk factors of added sugars from the two largest sources of added sugars consumed in the
American diet (SUC and HFCS) at levels up to the 90th percentile population consumption level for
fructose. We explored three different levels of added sugar consumption: 8% of calories (roughly the
upper level of consumption recommended by the AHA and WHO; 18% of calories (slightly above the
average consumption in the United States); and 30% of calories (slightly above the upper limit
recommended by the IOM and DGAs 2010). These levels represent the consumption 25th, 50th and 90th
percentile population consumption levels of fructose in the American population [17]. We hypothesized
that these two commonly consumed sugars at ranges of normal human consumption would not adversely
impact on risk factors for CHD, that there would be no differences in these parameters between the
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recommendations of the AHA, WHO and IOM and that there would not be differences between SUC
and HFCS related to these measures.
2. Material and Methods
2.1. Study Design
This was a randomized, prospective, parallel group, blinded study to assess the effects of consuming
three different levels of SUC vs. HFCS as components of usual diets. Four hundred sixty five normal
weight, overweight and obese subjects between the ages of 20–60 years old were randomized in the
study. The present data were produced from the 355 participants who completed the intervention
(see Figure 1). Both staff members and subjects were blinded as to whether or not participants in the trial
were consuming SUC or HFCS. Staff members were, however, aware of whether the subjects were
consuming 8%, 18% or 30% of calories as added sugar (25th, 50th and 90th percentile for fructose
consumption), since this information was needed in order to prescribe the remainder of the eucaloric
diet. Subjects were counseled in private counseling rooms in individual sessions to avoid the possibility
of subjects talking to individuals in other groups. The duration of the study was 10 weeks for each
participant. The study was approved by the Western Institutional Review Board, and all subjects signed
informed consent forms.
2.2. Subjects
Men and women between the ages of 20–60 years old with a body mass index (BMI) of 23–35 kg/m2
were recruited. Individuals could not be currently enrolled in a commercial weight loss program or
taking weight loss medication or supplements. Individuals were excluded if they had experienced a
change in weight of greater than 3% of current body weight in the past 30 days, were currently using
tobacco products or had utilized such products within the past year, had uncontrolled hypertension
(≥140/90 mmHg), or were diagnosed with type 1 or type 2 diabetes, or had thyroid disease and either not
taking medication or the dosage changed within the past six months, or a history of surgical procedure
for weight loss, or a major surgery within three months of enrollment, or a history of heart problems
(e.g., bypass surgery, myocardial infarction, etc.) within three months of enrollment. Individuals were
also excluded if orthopedic limitations would interfere with regular physical activity, if they had a
history of gastrointestinal disorders or diagnosed eating disorders, a history or the presence of cancer or
congestive heart failure. Women who were pregnant, lactating or trying to become pregnant, taking any
prescription medication for less than three months, or any individual consuming ≥14 alcoholic drinks
per week were also excluded. A known allergy to SUC or HFCS, participation in another clinical
trial within 30 days prior to enrollment, lactose intolerance or any other significant food allergy were
also excluded.
Interested individuals were initially screened over the phone to determine eligibility based on
self-reported data utilizing a standardized screening form and phone script to ensure that individuals
were screened in a consistent manner. Self-reported data, including height and weight, were verified
during the initial clinical visit. Fasting blood samples were also obtained for lipids, glucose and
C-reactive protein (CRP) and uric acid (only available in a subset of 81 participants).

Nutrients 2014, 6

3156
Figure 1. Study flow chart.
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Each subject performed a second screening visit approximately one week later. During this visit,
body composition was determined by dual X-ray absorptiometry (General Electric iDXA, Madison, WI,
USA). Total lean mass, percent total body fat and percent body fat were all determined by a DXA scan.
All females were required to have a negative serum pregnancy test prior to DXA testing. During this
visit, research dietitians also assessed participant dietary intake by analyzing a completed 3-day food
record using the Nutrient Data System for Research (NDS-R) software (University of Minnesota,
Minneapolis, MN, USA). Following the 10-week intervention, repeat measurements of body
composition and a repeat 3-day food record were obtained. At this time, another fasting blood sample
was also obtained. All cholesterol samples were sent to a certified, research-based laboratory with error
rates of less than 1%.
2.3. Dietary Plans
Sugar was provided in the form of 1% fat, sweetened milk (Tetra Pak, Denton, TX, USA).
All participants were weight stable upon enrolling in the study, and each participant was prescribed an
amount of milk, so that the added sugar contributed a certain percentage of the calories needed to
maintain their initial weight. The prescriptions were as follows:
Group 1: 8% of calories required for weight maintenance provided by added sucrose
(low consumption of fructose: 25th percentile of population consumption of fructose).
Group 2: 8% of calories required for weight maintenance provided by added HFCS
(low consumption of fructose: 25th percentile of population consumption of fructose).
Group 3: 18% of calories required for weight maintenance provided by added HFCS
(moderate consumption of fructose: 50th percentile of population consumption of fructose).
Group 4: 18% of calories required for weight maintenance provided by added sucrose
(moderate consumption of fructose: 50th percentile of population consumption of fructose).
Group 5: 30% of calories required for weight maintenance provided by added HFCS
(high consumption of fructose: 90th percentile of population consumption of fructose).
Group 6: 30% of calories required for weight maintenance provided by added sucrose
(high consumption of fructose: 90th percentile of population consumption of fructose).

in milk
in milk
in milk
in milk
in milk
in milk

The weight maintenance energy intake level was estimated using the Mifflin St. Jeor equation [18] for
resting energy expenditure (REE) (with activity factor). Participants were instructed on how to account
for the liquid calories in the milk, but instructed to otherwise eat their usual diet. The milk was
distributed on a weekly basis, at which time, the body weight was measured and approaches to account
for the liquid calories reinforced if weight gain was observed. However, no structured plan was provided
to protect against potential weight gain or to counteract observed weight gain. Compliance was
measured by evaluation of self-reported checklists that participants completed with each serving of milk
consumed and that were handed in during the weekly milk distribution visit.
Participants were blinded to both the type and amount of sugar in the milk they consumed. Research
staff were blinded to the type of sugar in each type of milk, but needed to be aware of the amount of
sugar, so that the appropriate prescriptions could be made.
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2.4. Data Analysis
Data were checked for normalcy and analyzed using a 2 (sugar type) × 3 (sugar level) analysis of
variance with repeated measures (pre and post). Only data on those who completed the intervention were
included in the analysis. Changes over the course of ten-weeks (Week 10 min baseline) were calculated
and between group differences assessed by one-way ANOVA with Tukey’s post hoc comparisons to
probe significant interaction effects. Within group changes were also tested as appropriate using paired
t-tests without corrections for multiple comparisons. For all analyses, the alpha value was set at 0.05. All
data were analyzed using SPSS Advanced Statistics V-18 (IBM, Armonk, NY, USA).
3. Results
3.1. Subjects
Of the 480 participants enrolled in the study, 355 (male = 165, female = 190) completed the 10-week
intervention (26% dropout rate). On average, those who dropped out or who were withdrawn by
investigators for non-compliance were similar in age and other demographic parameters compared with
those who finished. A lack of compliance with the consumption of the prescribed amount of sweetened
milk was the primary reason for participant attrition. Other reasons included participant unwillingness to
commit to the time required, intolerance of the milk or the unwillingness to consume the amount
prescribed, moving out of town, pregnancy and general dissatisfaction with the time commitment related
to the study. Dropout rates were similar across all six groups.
Baseline subject data are found in Table 1.
3.2. Dietary Intake
Compliance to the consumption of sweetened milk in all six intervention groups was very high with
>95% of all prescribed servings being consumed over the 10-week intervention period in all groups.
Compliance was measured by daily food checklists, which were reviewed on a weekly basis with each
subject by a research nutritionist. Sweetened milk consumption produced increases in the entire cohort
in energy intake, carbohydrates, protein, total sugar and added sugar intake and a decrease in fat intake
(p < 0.001). There was a significant time by sugar level interaction (p < 0.001) for all dietary
components, except for fat intake. The combined 30% groups had greater increases than both the 8% and
18% groups in energy intake (650.2 ± 682.0 kcal vs. 15.0 ± 703.2 kcal and 325.2 ± 688.1 kcal) and
protein (30.6 ± 31.7 g vs. 13.4 ± 31.5 g and 16.6 ± 29.7 g), whereas increases in a step-wise fashion
according to sugar intake level were observed for carbohydrates (159.7 ±109.3 g vs. 94.1 ±91.2 g vs.
33.3 ± 100.4 g), total sugar (182.3 ±84.6 g vs. 103.2 ± 57.6 g vs. 55.1 ± 55.6 g) and added sugar intake
(131.1 ± 69.2 g vs. 74.1 ± 46.1 g vs. 26.7 ± 49.3 g). Data for each of the six groups individually and for
the entire combined cohort are presented in Table 2.
3.3. Body Mass and Adiposity
In the entire cohort, there were significant increases in weight, BMI, percent body fat, fat mass,
fat-free mass (p < 0.001) and waist circumference (p < 0.05). Data for each of the six groups and the
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entire combined cohort are presented in Table 3. There were significant time × sugar level interactions
for body weight, BMI and fat mass (p < 0.05), with post hoc analysis revealing that the highest level of
sugar intake produced greater increases in body weight and BMI than either the 8% and 18% groups and
a greater increase in fat mass than in just the 8% group (Figure 2). The combined HFCS groups had a
lower increase in fat-free mass (51.4 ± 10.3 kg vs. 51.6 ± 10.1 kg) than the combined sucrose groups
(53.2 ± 11.5 kg vs. 53.8 kg, interaction p < 0.05). For no measure of weight or adiposity were the
time × sugar group × sugar level interactions significant (p > 0.05).
3.4. Risk Factors for CHD
Drinking sugar-sweetened low-fat milk produced increases in the entire cohort in triglycerides
(p < 0.001) and CRP (p < 0.01) and a decrease in HDL (p < 0.05), but there were no changes in any other
risk factor (Table 4). There were no differences in the response to sugar type or sugar concentration
when each was assessed independently. However, there was a significant time × sugar type × sugar level
interaction for systolic blood pressure (p < 0.05); a statistically significant decrease was observed in the
8% sucrose group (p < 0.01), but no changes were observed in any of the other five groups.
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Figure 2. The effect of sugar consumption level on body weight and measures of adiposity.
* A greater increase than 8% and 18%, p < 0.05. † A greater increase than 8%, p < 0.05.
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Table 1. Baseline characteristics of the 355 participants who completed the intervention.

Baseline

Total (n = 355);

8% SUC (n = 58) 1

8% HFCS (n = 69) 1

18% HFCS (n = 60)

18% SUC (n = 64)

30% HFCS (n = 51)

30% SUC (n = 53)

Characteristics

M = 165, F = 190

M = 32, F = 26

M = 27, F = 42

M = 30, F = 30

M = 26 F = 38

M = 23, F = 28

M = 27, F = 26

Age (years)

40.19 ± 11.59

38.62 ± 12.33

38.93 ± 11.65

40.43 ± 11.33

41.30 ± 11.10

43.41 ± 11.33

38.85 ± 11.56

Weight (lbs)

169.11 ± 30.64

175.58 ± 32.93

168.63 ± 31.19

168.42 ± 30.35

165.85 ± 30.50

172.73 ± 27.58

163.90 ± 30.46

BMI

26.99 ± 3.57

27.55 ± 3.94

27.06 ± 3.73

27.06 ± 3.51

26.25 ± 3.06

27.91 ± 3.69

26.19 ± 3.27

SBP (mmHg)

109.42 ± 10.91

111.02 ± 11.22

107.65 ± 10.90

108.37 ± 9.51

107.64 ± 11.06

112.35 ± 11.28

110.43 ± 11.04

DBP (mmHg)

72.18 ± 7.97

72.00 ± 8.01

71.64 ± 6.71

72.15 ± 7.74

70.70 ± 8.87

74.66 ± 8.19

72.54 ± 8.09

Glucose (mg/dL)

89.49 ± 6.42

90.83 ± 6.15

89.39 ± 6.15

89.56 ± 6.08

88.52 ± 6.63

90.00 ± 6.74

88.77 ± 6.85

1

HFCS = high fructose corn syrup, SUC = Sucrose. Beverages included HFCS- or sucrose-sweetened low-fat milk to provide 8%, 18% or 30% of calories from added sugar. M = Male; F = Female.

Table 2. Daily dietary intake over the course of ten weeks of sugar-sweetened milk consumption.

Dietary Intake

8% Sucrose

8% HFCS 1

18% HFCS

18% Sucrose

30% HFCS

30% Sucrose

Pooled Cohort 2

Energy Intake

Pre

2163.7 ± 656.5

2000.3 ± 690.3

2012.1 ± 680.6

2107.1 ± 799.8

1936.1 ± 626.2

2147.0 ± 911.0

2059.9 ± 732.2

(kcal)

Post

2230.9 ± 668.7

2171.9 ± 674.3

2364.4 ± 762.1

2406.0 ± 794.2

2641.9 ± 640.6

2743.6 ± 840.5

2411.7 ± 755.9 ***

Pre

78.4 ± 31.9

73.8 ± 30.1

77.6 ± 34.0

85.2 ± 45.8

74.6 ± 29.4

76.7 ± 37.1

77.7 ± 35.2

Post

74.7 ±30.5

70.7 ± 30.7

72.3 ± 36.6

73.8 ±34.7

70.6 ± 26.8

68.9 ± 29.1

71.8 ± 31.5 ***

Fat (g)

Carbohydrate (g)

Protein (g)

Total Sugar (g)

Added Sugar (g)

Pre

267.2 ± 86.3

241.4 ± 88.4

242.9 ± 86.2

249.7 ± 80.4

243.7 ± 92.2

275.9 ±140.1

252.9 ± 97.0

Post

286.6 ± 82.8

286.0 ± 85.1

339.6 ± 105.2

341.3 ± 101.9

405.8 ± 96.0

433.3 ± 138.5

345.1 ± 115.4 ***

Pre

92.3 ± 32.7

88.5 ± 43.6

86.5 ± 32.7

85.6 ± 32.5

78.1 ± 25.0

89.9 ± 41.9

87.0 ± 35.7

Post

105.4 ± 36.2

102.3 ± 35.9

101.4 ± 33.2

103.9 ± 37.1

112.9 ± 28.4

116.4 ± 39.7

106.7 ± 35.5 ***

Pre

109.9 ± 46.8

96.8 ± 40.9

105.0 ± 49.4

106.8 ± 43.1

105.9 ± 45.1

114.1 ± 87.3

106.0 ± 53.6

Post

158.1 ± 49.3

157.5 ± 45.0

206.4 ± 62.6

211.7 ± 60.6

285.1 ± 69.2

299.3 ± 91.3

215.9 ± 83.8 ***

Pre

71.3 ± 45.2

60.7 ± 37.6

62.6 ± 42.4

71.9 ± 42.0

73.7 ± 41.9

71.4 ± 75.7

68.2 ± 48.4

Post

91.0 ± 40.5

93.1 ± 39.1

138.6 ± 45.1

144.1 ± 51.9

199.4 ± 56.7

207.6 ±66.0

142.6 ±67.3 ***

Time × Sugar

Time × Sugar

Time × Sugar

Type Interaction

Level Interaction

p

p

0.236

<0.001

0.944

0.346

0.530

0.825

0.282

<0.001

0.671

0.578

<0.001

0.367

0.886

<0.001

0.516

0.740

<0.001

0.288

Type× Level
Interaction
p

*** Different than pre, p < 0.001; Beverages included HFCS- or sucrose-sweetened low-fat milk to provide 8%, 18% or 30% of the calories required for weight maintenance. 1 HFCS = high fructose corn syrup;
2

“Pooled cohort” includes pooled data from all 355 participants who consumed sugar-sweetened, low-fat milk for ten weeks.
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Table 3. Weight and adiposity over the course of ten weeks of sugar-sweetened milk consumption.
Time × Sugar

Body Composition

Body Weight (lbs)

8% Sucrose

8% HFCS

18% HFCS

18% Sucrose

30% HFCS

30% Sucrose

Pooled Cohort

Pre

175.6 ± 32.9

168.6 ± 31.2

168.6 ± 31.2

165.8 ± 30.5

172.7 ± 27.6

163.9 ± 30.5

169.1 ± 30.6

Post

178.0 ± 34.1

170.5 ±32.5

169.9 ± 30.6

168.2 ± 32.7

175.8 ± 28.8

168.2 ± 31.4

171.6 ± 31.8 ***

Pre

27.6 ± 3.9

27.1 ±3.7

27.1 ± 3.5

26.3 ± 3.1

27.9 ± 3.7

26.2 ± 3.3

27.0 ± 3.6

Post

27.9 ± 4.1

27.4 ± 4.0

27.3 ± 3.6

26.6 ± 3.4

28.4 ± 3.9

26.9 ± 3.3

27.4 ± 3.7 ***

Waist Circumference

Pre

85.7 ± 10.0

84.9 ± 9.9

84.8 ± 10.1

83.1 ± 8.9

87.1 ± 9.2

83.0 ± 10.4

84.7 ± 9.8

(cm)

Post

86.0 ± 10.0

84.7 ± 10.4

84.7 ± 9.9

83.7 ± 9.9

87.5 ± 9.5

83.8 ± 10.3

85.0 ± 10.0 *

BMI (kg/M2)

Body Fat Percentage
Fat Mass (kg)
Fat Free Mass (kg)

Pre

32.7 ± 9.1

35.2 ± 9.0

32.6 ± 9.0

32.4 ± 8.1

37.1 ± 8.1

31.5 ± 8.5

33.6 ± 8.8

Post

32.7 ± 9.2

35.4 ± 9.1

33.0 ± 8.8

33.2 ± 8.2

37.5 ± 8.0

32.4 ± 8.1

34.1 ± 8.7 ***

Pre

27.1 ± 11.5

26.2 ± 8.9

24.7 ± 9.0

23.7 ± 7.0

28.5 ± 8.2

22.3 ± 7.3

25.4 ± 8.9

Post

26.4 ± 9.8

26.8 ± 9.5

25.2 ± 8.8

24.8 ± 7.5

29.6 ± 9.0

23.7 ± 7.6

26.1 ± 8.9 ***

Pre

55.7 ± 10.9

50.6 ± 10.9

53.0 ± 10.7

52.8 ± 12.4

50.6 ± 9.3

51.3 ± 10.9

52.3 ± 10.9

Post

56.3 ± 11.2

50.8 ± 11.1

53.1 ± 10.1

53.2 ± 12.7

50.9 ± 9.0

52.1 ± 11.1

52.7 ± 11.0 ***

Time × Sugar

Time × Sugar

Type

Level

Type × Level

Interaction

Interaction

Interaction

p

p

p

0.114

0.018

0.855

0.165

0.016

0.814

0.054

0.268

0.943

0.293

0.055

0.389

0.778

0.022

0.128

0.038

0.398

0.886

* Different than pre p < 0.05; *** different than pre, p < 0.001. Beverages included HFCS- or sucrose-sweetened low-fat milk to provide 8%, 18% or 30% of the calories required for weight maintenance. “Pooled
cohort” includes pooled data from all 355 participants who consumed sugar-sweetened, low-fat milk for ten weeks.
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Table 4. Risk factors for cardiovascular disease over the course of ten weeks of sugar-sweetened milk consumption.
Time × Sugar

Risk Factors

8% Sucrose

8% HFCS

18% HFCS

18% Sucrose

30% HFCS

30% Sucrose

Pooled Cohort

Systolic Blood

Pre

111.0 ± 11.2

107.4 ± 10.8

108.2 ± 9.5

107.6 ± 11.1

112.4 ± 11.3

110.4 ± 11.0

109.4 ± 10.9

Pressure (mmHg)

Post

107.0 ± 11.1 **

108.7 ± 10.6

107.7 ± 9.2

106.3 ± 11.0

109.4 ± 12.3

111.3 ± 11.1

108.3 ± 10.9

Diastolic Blood

Pre

72.0 ± 8.0

71.5 ± 6.7

72.0 ± 7.8

70.7 ± 8.9

74.7 ± 8.2

72.5 ± 8.1

72.1 ± 8.0

Pressure (mmHg)

Post

70.6 ± 8.7

71.0 ± 8.0

70.3 ± 7.6

71.1 ± 8.0

73.1 ± 7.4

71.8 ± 8.3

71.3 ± 8.0

Cholesterol (mg/dL)
Triglycerides (mg/dL)
HDL (mg/dL)
LDL (mg/dL)

Pre

178.2 ± 36.8

181.2 ± 39.2

184.3 ± 40.1

188.5 ± 30.7

185.1 ± 35.8

183.5 ± 42.8

183.5 ± 37.5

Post

176.0 + 37.0

179.6 + 38.0

185.2 + 45.7

190.9 + 35.5

187.9 + 41.6

187.9 + 47.2

184.4 + 40.8

Pre

110.3 ± 6.6

97.9 ± 43.4

111.1 ± 55.3

97.3 ± 46.5

101.3 ± 48.5

108.5 ± 60.7

104.1 ± 51.8

Post

111.9 ± 56.5

110.8 ± 8.7

109.0 ± 54.2

109.3 ± 60.3

119.3 ± 75.8

126.9 ± 83.1

114.1 ± 64.7 ***

Pre

50.8 ± 14.9

53.1 ± 139

51.0 ± 13.0

54.2 ± 16.5

51.8 ± 13.3

52.9 ± 12.2

52.4 ± 14.1

Post

50.1 ± 13.9

52.1 ± 12.3

50.8 ± 13.5

54.3 ± 15.3

49.8 ± 12.2

52.0 ± 13.9

51.6 ± 13.6 *

Pre

105.6 ±33.8

108.4 ± 33.3

111.0 ± 33.1

114.8 ± 25.4

113.0 ± 31.0

108.9 ± 35.8

110.3 ± 32.0

Post

103.6 ± 305

105.2 ± 31.3

112.6 ± 39.3

114.7 ± 28.5

114.5 ± 36.0

110.5 ± 38.9

110.0 ± 34.1

Pre

90.0 ± 32.

89.1 ± 6.0

89.6 ± 90.6

88.4 ± 6.6

89.6 ± 6.7

88.8 ±6.8

89.4 ± 6.4

Post

91.4 ± 9.6

87.9 ± 9.8

90.6 ± 7.7

88.8 ± 7.7

91.7 ± 6.7

90.2 ± 8.1

90.0 ± 8.5

C reactive Protein

Pre

1.5 ± 1.6

1.9 ± 1.9

1.6 ± 1.6

2.0 ± 1.8

2.1 ± 2.1

1.5 ± 1.8

1.8 ± 1.8

(mg/L)

Post

2.1 ± 2.1

2.4 ± 2.3

2.0 ± 1.9

2.1 ± 2.1

2.1 ± 1.9

1.6 ± 1.3

2.1 ± 2.0 **

Pre

5.3 ± 1.5

5.1 ± 1.4

6.0 ± 1.9

5.4 ± 1.3

5.0 ± 1.8

5.4 ± 1.2

5.4 ± 1.6

Post

5.7 ± 1.2

5.1 ± 1.1

6.0 ± 2.0

5.6 ± 1.4

5.0 ± 1.5

5.6 ± 1.8

5.5 ± 1.5

Glucose (mg/dL)

Uric Acid (mg/dL)

Time × Sugar

Time × Sugar

Type

Level

Type × Level

Interaction

Interaction

Interaction

p

p

p

0.527

0.937

0.011

0.445

0.943

0.395

0.612

0.379

0.904

0.595

0.136

0.193

0.523

0.292

0.822

0.957

0.370

0.897

0.878

0.166

0.403

0.679

0.096

0.597

0.138

0.849

0.377

* Different than pre p < 0.05; ** different than pre, p < 0.01; *** different than pre, p < 0.001. Beverages included HFCS- or sucrose-sweetened low-fat milk to provide 8%, 18% or 30% of the calories required for
weight maintenance. “Pooled cohort” includes pooled data from all 355 participants who consumed sugar-sweetened, low-fat milk for ten weeks.
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4. Discussion
This blinded, randomized, prospective study compared changes in weight and body composition,
lipids, blood pressure and uric acid in individuals before and after a 10-week, free living intervention
during which low-fat (1%) milk was prescribed sweetened with either SUC or HFCS to deliver 8%, 18%
or 30% of calories from the sweetener (25th, 50th and 90th percentile population levels for fructose
consumption) in the context of mixed nutrient diets. These findings confirmed our hypothesis that
consumption of sugars up to the 90th percentile population consumption level does not adversely impact
cholesterol, LDL, blood pressure or glucose in the context of a well-designed, supervised, mixed
nutrient diet program. To our knowledge, this is the first attempt to examine the metabolic impacts of
this range of sugar and, more specifically, fructose consumption levels through normally consumed
sugars amongst individuals in a free living environment.
In the current study, despite consuming levels of added sugars at the 90th percentile population
consumption level for fructose consumption, individuals did not have any increase in their total
cholesterol or LDL. It should be noted that these findings are different from those of some previous
investigators, who have reported that added sugar consumption may increase both cholesterol and
LDL [19–22]. It should also be noted that since the added sugars in the current study were delivered in
low-fat milk, the increased consumption of vitamin D may have contributed to some of the results we
observed [23,24]. In particular, vitamin D may contribute to LDL reduction. Thus, our reported results
on cholesterol parameters must be treated with some caution. The current study also showed a 10%
increase in triglycerides. It should be emphasized that both pre and post levels of triglycerides were
within population established norms (104.1 ± 51.8 vs. 114.1 ± 64.7, p < 0.001). Other investigators have
also reported the increased triglycerides following increased carbohydrate consumption, particularly in
studies where weight gain occurs [22,25,26]. In the current study, small decreases in HDL were also
observed (<1 mg/dL).
In the current study, individuals increased their caloric consumption by approximately 350 kcal/day.
This resulted in weight gain and increased adiposity. Some epidemiologic studies have suggested that
increased consumption of sugar-sweetened beverages may be associated with increased risk of
obesity [3,4,27–29]. However, we have reported in previous studies that average consumption of added
sugars does not increase body mass [30]. We have also reported that average consumption of either
HFCS or SUC does not prevent weight loss when consumed as part of a well-designed, hypocaloric
diet [31]. In the present study, the highest level of sugar intake did produce the greatest increase in
weight and other measures of adiposity. This was in line with an overall greater increase in energy intake
in the highest sugar intake groups, which likely provides a better explanation for the differences in
weight gain rather than being due to the specific obesogenic effects of sugar. Thus, issues related to
added sugars and weight gain and obesity remain undecided. Additional studies, perhaps of longer
duration, will be required to clarify this area.
It has been argued that the unique metabolism of fructose, when compared with glucose, may
contribute to increased levels of uric acid, leading to endothelial dysfunction and resultant increases in
blood pressure [9,32,33]. Other studies have yielded different results showing no increases in blood
pressure in response to added sugars [34]. However, in the current study, no increases in either systolic
or diastolic blood pressure occurred at any level of added sugar consumption, nor did increases occur in
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uric acid. Thus, whether or not fructose consumption, even up to the 90th percentile of population
consumption levels, results in either increased blood pressure or uric acid production is not supported by
the current study and will require future studies for further clarification. It should also be noted that in
some studies, increased calcium consumption has resulted in lower blood pressure [35,36]. Thus, our
data in the area of blood pressure must be treated with some caution.
There is a significant body of evidence that suggests that there is no difference in the effect when
comparing the two primary sources of fructose in the American diet, HFCS and sucrose [30,31,37–40].
In the present study, there was a greater increase in fat-free mass in the combined sucrose group than in
the HFCS group, but no other differences were observed. It should also be noted that at every level of
HFCS or SUC consumption up to the 90th percentile population consumption levels [17] in the current
research trial, there were no differences between HFCS or SUC in any parameter measured. This
provides further data to a growing body of scientific literature demonstrating that by every parameter yet
measured in human beings, there are no metabolic differences between HFCS and SUC.
The strengths of the current study include its relatively large sample and the fact that it was a blinded,
randomized, prospective study that explored a range of normal population consumed levels of fructose
delivered through the sweeteners that are commonly consumed in the human diet, SUC and HFCS.
Furthermore, levels of compliance with the intervention of drinking the sweetened milk were extremely
high. The weaknesses are that the subjects were followed for only 10 weeks and that subjects over the
age of 60, children and adolescents were excluded. Adolescents represent the highest fructose
consuming group in the United States [17]. It should also be noted that 54% of participants in the current
study were female, which may limit the ability of these data to be generalized to the public. Some animal
data suggest that gender differences influence responses to fructose [41,42]. In particular, young women
appear more resistant to fructose-induced hypertriglyceridemia than males. Since HFCS, sucrose and
fructose consumption in the diets could not be measured, the actual differences in intake of these two
sugars remain unknown, which should be taken into consideration when interpreting these data.
5. Conclusions
In summary, the current study showed that there were little differences over a 10-week period in free
living subjects consuming average population consumption levels of fructose in the commonly
consumed sugars of SUC and HFCS. What differences were present were primarily the result of the total
intake of sugar and, subsequently, energy intake, rather than the identity of the sugar. Furthermore, there
were no increases in blood pressure or uric acid measurements for these individuals. The expected
increase in triglycerides did occur, which is consistent with both the levels of added sugars consumed, as
well as the slight weight gain, which occurred over the entire cohort [43]. Importantly, while body
weight and adiposity did increase in accordance with increases in sugar intake, there were no subsequent
differences in metabolic parameters when comparing 8% of calories from added sugars, a level
consistent with the upper limit recommended by the AHA [2] and WHO [14] with 30% of calories,
which is comparable to the upper limit recommended by the IOM [15] and DGAs 2010 [16]. Our
findings suggest that the issue of the appropriate upper limit for added sugar consumption is far from
being settled.
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The cohort increased their caloric consumption by 355 kcal and gained, on average, approximately
two and one-half pounds over the 10-week trial, indicating the difficulty many individuals experienced
in incorporating these levels of added sugars into their diet. Whether these findings would persist in a
longer trial remains to be determined by future research.
Finally, this study adds to the expanding literature that dosage levels commonly consumed by
human beings ranging from the 25th to 90th percentile of fructose consumption of HFCS and SUC
behave similarly.
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